AmTech Bioengineering
Latest round
- Series A
Last raised
- Aug 2021
Total raised
- Undisclosed
Investors
- 1
About AmTech Bioengineering
, Inc. is a developer of biomedical and focuses on the production, sales and service in vitro diagnostic products. It has a trading company for the import and export of raw materials and products in Hong Kong, and a research and development center in Santiago. It also has 2600 square meters of office, research and development and GMP production base in Shenzhen. There are nearly 100 team members. The chairman of the board Dr. Xiaoru Chen, he was graduated from Johns Hopkins University. The company provides the products of biological and chemical raw materials, in vitro diagnostic reagent and automatic analyzer. It also provides the technology of protein engineering includes recombinant protein expression service, protein purification service and molecular biology services.
Who invested in AmTech Bioengineering
1 investor across 1 round
See all investors in AmTech Bioengineering
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Aug 23, 2021
Amount
Undisclosed
Investors
Questions about AmTech Bioengineering
Who invested in AmTech Bioengineering?
AmTech Bioengineering has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AmTech Bioengineering raised?
AmTech Bioengineering has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did AmTech Bioengineering last raise money?
AmTech Bioengineering's most recent round on record is a Series A, in Aug 2021.
What does AmTech Bioengineering do?
AmTech Bioengineering is a biotechnology company.
Where is AmTech Bioengineering headquartered?
AmTech Bioengineering is headquartered in Shenzhen, China.
Which VCs invest in companies like AmTech Bioengineering?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at AmTech Bioengineering's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like AmTech Bioengineering? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.